| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |